Selecky Christobel
SEC CIK 1849739 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| IBRX | ImmunityBio, Inc. | Dir | 159.5K | — | $3.00M | 8 | 2026-01-16 | 2026-07-01 |
Most active insiders at IBRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Simon Barry J. | Dir | — | $4.14M |
| 2 | Selecky Christobel | Dir | — | $3.00M |
| 3 | Cohen Cheryl | Dir | — | $1.25M |
| 4 | Sachs David C. | CFO | — | — |
| 5 | Adcock Richard | CEO, Pres, Dir | — | — |
| 6 | CALIFORNIA CAPITAL EQUITY, LLC | 10% | — | — |
| 7 | LAUER REGAN J | CAO | — | — |
| 8 | SOON-SHIONG PATRICK | See remarks, Dir, 10% | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-07-06 20:25 | 2026-07-01 | IBRX | ImmunityBio, Inc. | Selecky Christobel | Dir | M - OptEx | $2.99 | +159.5K | 159.5K | New | +$476.5K |
| DT | 2026-07-06 20:25 | 2026-07-01 | IBRX | ImmunityBio, Inc. | Selecky Christobel | Dir | S - Sale+OE | $9.02 | -159.5K | 0 | -100% | -$1.44M |
| DMT | 2026-07-01 17:04 | 2026-06-29+ | IBRX | ImmunityBio, Inc. | Selecky Christobel | Dir | M - OptEx | $2.94 | +96.7K | 1,000 | New | +$284.4K |
| DMT | 2026-07-01 17:04 | 2026-06-29+ | IBRX | ImmunityBio, Inc. | Selecky Christobel | Dir | S - Sale+OE | $9.01 | -96.7K | 0 | -100% | -$871.2K |
| D | 2026-02-24 | 2026-02-23 | IBRX | ImmunityBio, Inc. | Selecky Christobel | Dir | M - OptEx | $2.98 | +25.0K | 25.0K | New | +$74.5K |
| D | 2026-02-24 | 2026-02-23 | IBRX | ImmunityBio, Inc. | Selecky Christobel | Dir | S - Sale+OE | $10.00 | -25.0K | 0 | -100% | -$250.0K |
| DM | 2026-01-21 | 2026-01-16+ | IBRX | ImmunityBio, Inc. | Selecky Christobel | Dir | M - OptEx | $2.98 | +75.0K | 50.0K | New | +$223.5K |
| DM | 2026-01-21 | 2026-01-16+ | IBRX | ImmunityBio, Inc. | Selecky Christobel | Dir | S - Sale+OE | $5.84 | -75.0K | 0 | -100% | -$437.8K |
Purchase Sale Sale after option exercise All abbreviations